This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Sciwind Biosciences Co., Ltd., Sciwind Biosciences Co., Ltd.. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2026
Title: Wanjun Guo: Innovator in GLP-1 Derivative Research
Introduction
Wanjun Guo is a notable inventor based in Beijing, China. He has made significant contributions to the field of biochemistry, particularly in the development of innovative pharmaceutical compounds. His work focuses on enhancing the efficacy of therapeutic agents through novel modifications.
Latest Patents
Wanjun Guo holds a patent for an acylated GLP-1 derivative. This patent includes a GLP-1(7-37) polypeptide analogue, a fatty acid-modified derivative of the analogue, and a medicament that comprises the derivative. Additionally, the patent outlines a preparation method for the derivative and its use in the formulation of a medicament.
Career Highlights
Wanjun Guo is associated with Sciwind Biosciences Co., Ltd., where he applies his expertise in drug development. His innovative approach has led to advancements in the treatment of metabolic disorders, showcasing his commitment to improving healthcare outcomes.
Collaborations
Wanjun collaborates with esteemed colleagues, including Zheng Xu and Feng Li. Their combined efforts contribute to the ongoing research and development initiatives at Sciwind Biosciences Co., Ltd.
Conclusion
Wanjun Guo's work in the field of GLP-1 derivatives exemplifies the impact of innovative research on pharmaceutical development. His contributions are paving the way for new therapeutic options in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile